Exelixis (EXEL) EBITDA (2010 - 2026)
Exelixis' EBITDA came in at $255.4 million for Q2 2027, up 15.6% from $220.92 million a year earlier but down 1.1% from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) EBITDA (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jul 3, 2026, Exelixis reported EBITDA of $999.81 million, up 37.1% year-over-year; for FY2026, it was $901.25 million, up 42.3% from FY2025.
- EBITDA carries a five-year compound annual growth rate of 24.6% (FY2021 to FY2026).
- Going back by year, EBITDA was $633.42 million in FY2025, $196.6 million in FY2023 (-11.6%) and $222.36 million in FY2022 (-26.0%).
- The five-year range for quarterly EBITDA is $35.84 million (Q1 2025) to $283.2 million (Q2 2025).
- Year-over-year, EBITDA has increased for four consecutive quarters, with growth averaging 96.7% over the last six quarters.
- Business Quant data shows EXEL's EBITDA at $258.29 million (Q1 2027), $242.16 million (Q4 2026) and $243.96 million (Q3 2026) in the three quarters before Q2 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Exelixis | 14.53 Bn | 10.86 Bn | 608.03 Mn | 255.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 255.40 Mn |
| Apr 3, 2026 | 258.29 Mn |
| Jan 2, 2026 | 242.16 Mn |
| Oct 3, 2025 | 243.96 Mn |
| Jul 4, 2025 | 220.92 Mn |
| Apr 4, 2025 | 194.20 Mn |
| Jan 3, 2025 | 170.85 Mn |
| Sep 27, 2024 | 143.53 Mn |
| Jun 28, 2024 | 283.20 Mn |
| Mar 29, 2024 | 35.84 Mn |
| Dec 29, 2023 | 88.31 Mn |
| Sep 29, 2023 | -11.29 Mn |
| Jun 30, 2023 | 83.89 Mn |
| Mar 31, 2023 | 35.69 Mn |
| Dec 30, 2022 | -42.13 Mn |
| Sep 30, 2022 | 88.28 Mn |
| Jul 1, 2022 | 88.48 Mn |
| Apr 1, 2022 | 87.73 Mn |
| Dec 31, 2021 | 119.95 Mn |
| Oct 1, 2021 | 56.43 Mn |
API Access
Exelixis EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();